Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04985773 · ClinicalTrials.gov registry record · NA
A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon
A NA study, sponsored by Infraredx.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT04985773 is a NA study that has completed, run by Infraredx. The registered enrollment target is 200 participants.
The verdict
NCT04985773, a NA study, has completed, sponsored by Infraredx.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate safety and effectiveness of the Lacrosse NSE ALPHA coronary dilatation catheter during PCI in subjects with stenotic coronary arteries.
Interventions
- DEVICE Lacrosse NSE ALPHA coronary dilatation catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-12-17 |
| Est. Completion | 2022-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04985773
The ClinicalTrials.gov registry entry for NCT04985773 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Infraredx, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lacrosse NSE ALPHA coronary dilatation catheter is the first listed.
NCT04985773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04985773 about?
NCT04985773 is a clinical study titled "A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon". The objective of this study is to evaluate safety and effectiveness of the Lacrosse NSE ALPHA coronary dilatation catheter during PCI in subjects with stenotic coronary arteries.
What is the current status of trial NCT04985773?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2021-12-17. Estimated completion is 2022-12-16.
What interventions are being tested in trial NCT04985773?
The interventions under investigation include: Lacrosse NSE ALPHA coronary dilatation catheter (DEVICE).
Who is sponsoring clinical trial NCT04985773?
This trial is sponsored by Infraredx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.